- Home
- TVTX vs FULT Comparison
TVTX vs FULT Comparison
Compare TVTX & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TVTX | FULT |
|---|---|---|
| Founded | N/A | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.4B |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TVTX | FULT |
|---|---|---|
| Price | $48.93 | $23.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $75.14 | $26.25 |
| AVG Volume (30 Days) | ★ 2.3M | 1.6M |
| Earning Date | 11-02-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 3.13% |
| EPS Growth | ★ 92.89 | 32.48 |
| EPS | N/A | ★ 1.02 |
| Revenue | N/A | ★ $276,768,000.00 |
| Revenue This Year | $55.24 | $9.94 |
| Revenue Next Year | $43.78 | $5.60 |
| P/E Ratio | ★ N/A | $23.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.59 | $16.91 |
| 52 Week High | $68.73 | $25.23 |
Technical Indicators
Market Signals| Indicator | TVTX | FULT |
|---|---|---|
| Relative Strength Index (RSI) | 47.24 | 64.81 |
| Support Level | $49.46 | $24.14 |
| Resistance Level | $59.93 | $24.94 |
| Average True Range (ATR) | 2.67 | 0.49 |
| MACD | 0.37 | 0.17 |
| Stochastic Oscillator | 76.14 | 82.33 |
Price Performance
Historical ComparisonAbout TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
About FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.